6,070
Views
238
CrossRef citations to date
0
Altmetric
Brief Report

Distinctive patterns of DNA methylation associated with Parkinson disease

Identification of concordant epigenetic changes in brain and peripheral blood leukocytes

, , &
Pages 1030-1038 | Received 04 Jun 2013, Accepted 23 Jul 2013, Published online: 01 Aug 2013

References

  • Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron 2003; 39:889 - 909; http://dx.doi.org/10.1016/S0896-6273(03)00568-3; PMID: 12971891
  • Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388:839 - 40; http://dx.doi.org/10.1038/42166; PMID: 9278044
  • Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 1998; 152:367 - 72; PMID: 9466562
  • Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009; 14:478 - 500; http://dx.doi.org/10.1007/s10495-008-0309-3; PMID: 19165601
  • Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, et al. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson’s disease pathology. Brain 2009; 132:1795 - 809; http://dx.doi.org/10.1093/brain/awn323; PMID: 19052140
  • Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, et al. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol Dis 2008; 29:515 - 28; http://dx.doi.org/10.1016/j.nbd.2007.11.008; PMID: 18191405
  • Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011; 14:1345 - 51; http://dx.doi.org/10.1038/nn.2900; PMID: 21874013
  • Day JJ, Sweatt JD. DNA methylation and memory formation. Nat Neurosci 2010; 13:1319 - 23; http://dx.doi.org/10.1038/nn.2666; PMID: 20975755
  • Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009; 8:1056 - 72; http://dx.doi.org/10.1016/S1474-4422(09)70262-5; PMID: 19833297
  • Desplats P, Spencer B, Coffee E, Patel P, Michael S, Patrick C, et al. Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem 2011; 286:9031 - 7; http://dx.doi.org/10.1074/jbc.C110.212589; PMID: 21296890
  • Jowaed A, Schmitt I, Kaut O, Wüllner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson’s disease patients’ brains. J Neurosci 2010; 30:6355 - 9; http://dx.doi.org/10.1523/JNEUROSCI.6119-09.2010; PMID: 20445061
  • Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji T, et al. CpG Demethylation Enhances Apha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease. PLoS ONE 2010; 5:1 - 9; http://dx.doi.org/10.1371/journal.pone.0015522
  • Graeber MB. Biomarkers for Parkinson’s disease. Exp Neurol 2009; 216:249 - 53; http://dx.doi.org/10.1016/j.expneurol.2008.12.017; PMID: 19166835
  • Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, et al. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 2005; 11:6505 - 11; http://dx.doi.org/10.1158/1078-0432.CCR-05-0625; PMID: 16166426
  • He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, et al. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet 2010; 202:1 - 10; http://dx.doi.org/10.1016/j.cancergencyto.2010.05.018; PMID: 20804913
  • Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, et al. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004; 22:2363 - 70; http://dx.doi.org/10.1200/JCO.2004.10.077; PMID: 15197197
  • Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679 - 92; http://dx.doi.org/10.1038/nrg3270; PMID: 22945394
  • Jain K. The Handbook of Biomarkers. Humana Press 2010.
  • Burn DJ. Cortical Lewy body disease and Parkinson’s disease dementia. Curr Opin Neurol 2006; 19:572 - 9; http://dx.doi.org/10.1097/01.wco.0000247607.34697.a2; PMID: 17102696
  • Lee SH, Kim SS, Tae WS, Lee SY, Lee KU, Jhoo J. Brain volumetry in Parkinson’s disease with and without dementia: where are the differences?. Acta Radiol 2013; •••; http://dx.doi.org/10.1177/0284185113476029; PMID: 23474765
  • Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, et al. Cortical thinning is associated with disease stages and dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2013; 84:875 - 82; http://dx.doi.org/10.1136/jnnp-2012-304126; PMID: 23463873
  • Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 2012; 7:e46705; http://dx.doi.org/10.1371/journal.pone.0046705; PMID: 23071618
  • Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361; http://dx.doi.org/10.1371/journal.pone.0041361; PMID: 22848472
  • Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13:R43; http://dx.doi.org/10.1186/gb-2012-13-6-r43; PMID: 22703893
  • Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 2013; 41:Database issue D377 - 86; http://dx.doi.org/10.1093/nar/gks1118; PMID: 23193289
  • Nakamura T, Cho DH, Lipton SA. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp Neurol 2012; 238:12 - 21; http://dx.doi.org/10.1016/j.expneurol.2012.06.032; PMID: 22771760
  • Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288 - 95; http://dx.doi.org/10.1016/j.ygeno.2011.07.007; PMID: 21839163
  • Kibriya MG, Raza M, Jasmine F, Roy S, Paul-Brutus R, Rahaman R, et al. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med Genomics 2011; 4:50; http://dx.doi.org/10.1186/1755-8794-4-50; PMID: 21699707
  • Naumova OY, Lee M, Koposov R, Szyf M, Dozier M, Grigorenko EL. Differential patterns of whole-genome DNA methylation in institutionalized children and children raised by their biological parents. Dev Psychopathol 2012; 24:143 - 55; http://dx.doi.org/10.1017/S0954579411000605; PMID: 22123582
  • Efron BaT. R. An Introduction to the Bootstrap. Monographs on Statistics and Applied Probability 1993; 57:1 - 399
  • Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, Flynn J, et al. Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 2010; 5:5; http://dx.doi.org/10.1371/journal.pone.0013066; PMID: 20927376
  • Desplats P, Patel P, Kosberg K, Mante M, Patrick C, Rockenstein E, et al. Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease. Mol Neurodegener 2012; 7:49; http://dx.doi.org/10.1186/1750-1326-7-49; PMID: 23017109
  • Jakovcevski M, Bharadwaj R, Straubhaar J, Gao G, Gavin DP, Jakovcevski I, et al. Prefrontal Cortical Dysfunction After Overexpression of Histone Deacetylase 1. Biol Psychiatry 2013; •••; http://dx.doi.org/10.1016/j.biopsych.2013.03.020; PMID: 23664640
  • Miñones-Moyano E, Friedländer MR, Pallares J, Kagerbauer B, Porta S, Escaramís G, et al. Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction. RNA Biol 2013; 10:10; http://dx.doi.org/10.4161/rna.24813; PMID: 23673382
  • Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, et al. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol 2012; 13:R97; http://dx.doi.org/10.1186/gb-2012-13-10-r97; PMID: 23034122
  • Kumaran R, van der Brug M, Vandrovcova J, Ding J, Sharma S, Renton A, Dillman A, Lees A, Cookson MR, Bandopadhyay R. . Gene expression changes across multiple regions of the Parkinson’s disease brain. Gene Expression Omnibus (GEO) NCBI2011:Series GSE28894.
  • Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease. Neurogenetics 2006; 7:1 - 11; http://dx.doi.org/10.1007/s10048-005-0020-2; PMID: 16344956
  • Roth R.. Human body index - transcriptional profiling. Gene Expression Omnibus (GEO) NCBI2007:Series GSE7307.
  • Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, et al, Global PD Gene Expression (GPEX) Consortium. PGC-1α, a potential therapeutic target for early intervention in Parkinson’s disease. Sci Transl Med 2010; 2:52ra73; http://dx.doi.org/10.1126/scitranslmed.3001059; PMID: 20926834
  • Durrenberger PF, Grünblatt E, Fernando FS, Monoranu CM, Evans J, Riederer P, et al. Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study. Parkinsons Dis 2012; 2012:214714; PMID: 22548201
  • Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007; 3:e98; http://dx.doi.org/10.1371/journal.pgen.0030098; PMID: 17571925
  • Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A 2010; 107:16970 - 5; http://dx.doi.org/10.1073/pnas.1011751107; PMID: 20837543
  • Muller KE, LaVange L. M., Ramey, S.L. and Ramey, C.T. Power calculations for general multivariate models including repeated measures applications. J Am Stat Assoc 1992; 87:1209 - 26; http://dx.doi.org/10.1080/01621459.1992.10476281
  • Zhang Y, James M, Middleton FA, Davis RL. Transcriptional analysis of multiple brain regions in Parkinson’s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 2005; 137B:5 - 16; http://dx.doi.org/10.1002/ajmg.b.30195; PMID: 15965975
  • Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009; 130:234 - 9; http://dx.doi.org/10.1016/j.mad.2008.12.003; PMID: 19150625
  • Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001; 10:687 - 92; http://dx.doi.org/10.1093/hmg/10.7.687; PMID: 11257100
  • Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res 2012; 22:407 - 19; http://dx.doi.org/10.1101/gr.119867.110; PMID: 21613409
  • Benjamini YaHY. Controlling the False Discovery Rate: A Practical and Powerful Approch to Multiple Testing. J R Stat Soc Ser A Stat Soc 1995; 57:289 - 300
  • Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease. PLoS Genet 2011; 7:e1002141; http://dx.doi.org/10.1371/journal.pgen.1002141; PMID: 21738487
  • Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010; 74:97 - 109; http://dx.doi.org/10.1111/j.1469-1809.2009.00560.x; PMID: 20070850
  • Spencer CC, Plagnol V, Strange A, Gardner M, Paisan-Ruiz C, Band G, et al, UK Parkinson’s Disease Consortium, Wellcome Trust Case Control Consortium 2. Dissection of the genetics of Parkinson’s disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 2011; 20:345 - 53; http://dx.doi.org/10.1093/hmg/ddq469; PMID: 21044948
  • Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J Intern Med 2007; 261:488 - 99; http://dx.doi.org/10.1111/j.1365-2796.2007.01777.x; PMID: 17444888
  • Eisenhart C. The assumptions underlying the analysis of variance. Biometrics 1947; 3:1 - 21; http://dx.doi.org/10.2307/3001534; PMID: 20240414